BACKGROUND: The inhibition of the renin-angiotensin system in the diabetic condition was reported to enhance the sodium sensitivity of blood pressure. In patients with sodium-sensitive hypertension, high sodium intake reduces the nocturnal fall in blood pressure. Therefore, we examined the effects of the amount of sodium intake or diuretics in patients with diabetes treated with an angiotensin receptor blocker. METHODS: We recruited 32 Japanese type 2 diabetic patients with base line blood pressure > or =130/80 mmHg and treated with valsartan (80 mg daily). At baseline, 24-h ambulatory blood pressure and 24-h urinary excretion of sodium were measured. The patients were then randomly assigned to take either combination therapy with 50 mg of losartan plus 12.5 mg of hydrochlorothiazide or monotherapy with 160 mg of valsartan for 24 weeks. RESULTS: At baseline, 22 of 32 (69%) patients were classified as non-dippers, and the night/day ratio of mean arterial pressure was significantly correlated with 24-h urinary sodium excretion. The combination therapy resulted in a significantly higher fall than the monotherapy in 24-h mean, daytime, night-time and morning blood pressures. The night/day ratio of mean arterial pressure was significantly reduced from the baseline at the end of the study in the combination therapy group, but not in the monotherapy group. In non-dipper patients, the diminished nocturnal fall in blood pressure was restored by the combination therapy. CONCLUSIONS: Excessive intake of salt causes non-dipping and diuretics restored nocturnal BP fall in type 2 diabetic patients treated with angiotensin 2 receptor blockers.
RCT Entities:
BACKGROUND: The inhibition of the renin-angiotensin system in the diabetic condition was reported to enhance the sodium sensitivity of blood pressure. In patients with sodium-sensitive hypertension, high sodium intake reduces the nocturnal fall in blood pressure. Therefore, we examined the effects of the amount of sodium intake or diuretics in patients with diabetes treated with an angiotensin receptor blocker. METHODS: We recruited 32 Japanese type 2 diabeticpatients with base line blood pressure > or =130/80 mmHg and treated with valsartan (80 mg daily). At baseline, 24-h ambulatory blood pressure and 24-h urinary excretion of sodium were measured. The patients were then randomly assigned to take either combination therapy with 50 mg of losartan plus 12.5 mg of hydrochlorothiazide or monotherapy with 160 mg of valsartan for 24 weeks. RESULTS: At baseline, 22 of 32 (69%) patients were classified as non-dippers, and the night/day ratio of mean arterial pressure was significantly correlated with 24-h urinary sodium excretion. The combination therapy resulted in a significantly higher fall than the monotherapy in 24-h mean, daytime, night-time and morning blood pressures. The night/day ratio of mean arterial pressure was significantly reduced from the baseline at the end of the study in the combination therapy group, but not in the monotherapy group. In non-dipper patients, the diminished nocturnal fall in blood pressure was restored by the combination therapy. CONCLUSIONS: Excessive intake of salt causes non-dipping and diuretics restored nocturnal BP fall in type 2 diabeticpatients treated with angiotensin 2 receptor blockers.
Authors: J A Staessen; L Thijs; R Fagard; E T O'Brien; D Clement; P W de Leeuw; G Mancia; C Nachev; P Palatini; G Parati; J Tuomilehto; J Webster Journal: JAMA Date: 1999-08-11 Impact factor: 56.272
Authors: H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf Journal: JAMA Date: 2001-07-25 Impact factor: 56.272
Authors: José Boggia; Yan Li; Lutgarde Thijs; Tine W Hansen; Masahiro Kikuya; Kristina Björklund-Bodegård; Tom Richart; Takayoshi Ohkubo; Tatiana Kuznetsova; Christian Torp-Pedersen; Lars Lind; Hans Ibsen; Yutaka Imai; Jiguang Wang; Edgardo Sandoya; Eoin O'Brien; Jan A Staessen Journal: Lancet Date: 2007-10-06 Impact factor: 79.321
Authors: Funda Celik; Mohamed Ahdi; Eelco W Meesters; Arnold van de Laar; Dees P M Brandjes; Victor E A Gerdes Journal: Obes Surg Date: 2013-03 Impact factor: 4.129
Authors: Tatsuo Hosoya; Satoru Kuriyama; Iwao Ohno; Tetsuya Kawamura; Makoto Ogura; Masato Ikeda; Masahiro Ishikawa; Fumihiro Hayashi; Tatsuya Kanai; Haruo Tomonari; Michimasa Soejima; Kiyoaki Akaba; Goro Tokudome; S Endo; A Fukui; H Gomi; A Hamaguchi; K Hanaoka; Y Hara; Y Hara; T Hasegawa; H Hayakawa; M Hikida; K Hirano; M Horiguchi; M Hosoya; K Ichida; T Imai; T Ishii; H Ishikawa; C Kameda; T Kasai; A Kobayashi; H Kobayashi; M Kurashige; Y Kusama; H Maezawa; Y Maezawa; Y Maruyama; H Matsuda; N Matsuo; T Matsuo; Y Miura; M Miyajima; M Miyakawa; Y Miyazaki; M Mizuguchi; M Nakao; H Nokano; I Ohkido; Y Ohtsuka; K Okada; H Okamoto; H Okonogi; H Saikawa; H Saito; C Sekiguchi; Y Suetsugu; N Sugano; T Suzuki; T Suzuki; H Takahashi; Y Takahashi; S Takamizawa; K Takane; T Morita; K Takazoe; H Tanaka; S Tanaka; H Terawaki; R Toyoshima; N Tsuboi; T Udagawa; H Ueda; Y Ueda; M Uetake; S Unemura; M Utsunomiya; Y Utsunomiya; T Yamada; Y Yamada; Y Yamaguchi; H Yamamoto; T Yokoo; K Yokoyama; H Yonezawa; H Yoshida; M Yoshida; T Yoshizawa Journal: Clin Exp Nephrol Date: 2011-11-30 Impact factor: 2.801